COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

PI-88 in Hepatocellular Carcinoma After Hepatectomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00247728
Recruitment Status : Completed
First Posted : November 2, 2005
Last Update Posted : October 18, 2007
Medigen Biotechnology Corporation
Information provided by:
Progen Pharmaceuticals

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Primary Completion Date : No date given
Study Completion Date : June 2008
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 July 27, 2011
August 24, 2011
2 March 30, 2016
May 2, 2016